Skip to content

Vagus Nerve Stimulation In Patients Of Chronic Migraine

Effect Of Vagus Nerve Stimulation On Headache And Heart Rate Variability In Patients Of Chronic Migraine - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077261
Enrollment
32
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G437- Chronic migraine without aura

Interventions

Intervention1: transcutaneous auricular non-invasive Vagus nerve stimulation: transcutaneous auricular non-invasive Vagus nerve stimulation device from Soterix Medical hand-held Electrical Stimulation

Sponsors

Multidisciplinary Research Unit funded by Department of Health Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: diagnosed case of chronic migraine without aura and on pharmacological prophylaxis for the past 3 months. the patient should be able to provide informed consent for using the ta-VNS device and self-assessment scale.

Exclusion criteria

Exclusion criteria: History of Neurological disorder, cardiovascular disease, CVA, asthma, or any other co-morbidity that may cause sudden death. The patient is known to have auricular trauma or surgery that may affect the application of the ta-VNS device. Has uncontrolled high blood pressure, and a history of syncope or seizures. It is currently implanted with an electrical or neuro-stimulatory device. Has a history of substance abuse. Is pregnant or planning conception in the next three months. Is a participant in any other therapeutic clinical investigation or clinical trial in the preceding 30 days. Has a condition that compromises his/her ability to provide informed consent, comply with follow-up requirements, or provide self-assessments.

Design outcomes

Primary

MeasureTime frame
decrease in intensity , frequency and duration of headache with improvement in HIT6 score in 6 weeksTimepoint: decrease in intensity , frequency and duration of headache with improvement in HIT6 score in 6 weeks

Secondary

MeasureTime frame
effect on Heart Rate Variability at 6 weeksTimepoint: effect on Heart Rate Variability at 6 weeks

Countries

India

Contacts

Public ContactDr Samiksha Rana

ESIC Medical college and Hospital , Faridabad

drpandeyak@yahoo.co.in7042918222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026